showed a trendp = 0.148
Māori or Pacific ethnicity showed a trend toward greater HbA1c reduction (coefficient = −5.62, 95% CI: −13.27 to 2.02, p = 0.148).
Māori or Pacific ethnicity showed a trend toward greater HbA1c reduction (coefficient = −5.62, 95% CI: −13.27 to 2.02, p = 0.148).
HPV-positive LSCC showed a trend toward a better 5-year DSS (100% vs . 84.8%, p = 0.1485) and a significant improvement in the local/regional control rate (100% vs . 75%, p = 0.0494).
Hemoptysis positive patients showed a trend of a larger total growth of the pulmonary artery during follow up (3.82±2.77 mm vs. 2.68±2.81, p = 0.149) and a trend of a faster growth per month (0.156±0.146 vs. 0.063±0.151, p = 0.107).
The five TPM cases showed a trend ( p = 0.149) for decreased/absent HDAC9 expression in the nucleus of pNEN cells.
The data showed a trend that patients with high mGPS suffered earlier progression compared to those with low mGPS (54.3 vs 88.1 months, P = 0.149).
Intraoperative bleeding showed a trend toward lower volumes in the WeChat remote platform group (7.61 ± 3.86 vs. 6.88 ± 3.63 ml, p = 0.149, adjusted p = 0.085), though this difference did not reach statistical significance (Table 1 ).
The TAVR group showed a trend towards a higher 1-year all-cause mortality, compared with the SU-AVR group (7.0% vs 1.7%, p =0.149).
Compared to the non-HSCT group, the post-allo-HSCT group showed a trend toward a lower 2-year cumulative relapse rate (25.5% vs. 64.3%, P = 0.149) (Fig. 1C ), with overall relapse rates of 21.1% (4/19) and 38.9% (7/18), respectively.
However, analysis of the clinical presentation revealed that patients under agalsidase-beta tended to be older ( p = 0.1371) and showed a trend towards a longer ERT duration ( p = 0.1499) than patients receiving agalsidase-alfa (Additional file 3 : Table S3).
Furthermore, a recent retrospective analysis by De Roock et al., examined 579 patients with chemotherapy-refractory CRC who received cetuximab treatment, and revealed that patients with p.G13D-mutated tumors showed a trend toward a higher response rate than other KRAS -mutated tumors (6.3% versus 1.6%, p = 0.15).
Plasma TMA levels of the Con + IMC group showed a trend of a decrease compared to the Con group (0.08 μM vs. 0.15 μM, p = 0.15, Supplemental Fig.
Interestingly, α 1 increased significantly for dP2 and showed a trend to increase ( p < 0.15) for dP1 while its increase was far from the statistical threshold for the reference RRI ( p = 0.69).
Scars in Association with Mechanical Trauma Scars from mechanical trauma showed a trend towards higher rates of graft rejection ( p = 0.15) and failure ( p = 0.089) in inflamed corneas, although the results were not statistically significant.
In a generalized linear mixed model, HCWs with pain limitations [ 30 ] at baseline showed a trend ( F [1,60] = 2.11, p = 0.15) of making larger 6-month increases in the mean safety actions (Cohen’s d = 0.75) compared to those without limitations (Cohen’s d = 0.44; difference-in-difference Cohen’s d = 0.31).
Patients with carbapenem-resistant VARI had significantly greater ICU costs than patients with carbapenem-susceptible isolates (6053 USD (IQR 3806–7824) vs 3131 USD (IQR 2108–7551), p = 0.04) and after correction for adequacy of initial antibiotics and APACHE II score, showed a trend towards increased risk of in-hospital death (HR 2.82, 95% CI 0.75–6.75, p = 0.15).
In multivariable analysis, larger LA diameter showed a trend toward an increased risk of new-onset AF (OR 1.10 per mm, 95% CI 0.97–1.25, p = 0.15) among patients without previous AF, whereas sex, age, common risk factors, or cardiomyopathy were not significant predictors.
Histological subtype showed a trend toward association with progression (p = 0.15) and extent of resection (p = 0.067).
At baseline, diacerein-treated participants showed a trend (P < 0.15) toward lower systolic and diastolic blood pressures compared to placebo participants, which is consistent with more frequent use of ACE inhibitors.
However, the decrease in mean values observed in the visuospatial group only showed a trend ( p = 0.15).
Statistical comparison of the correlation coefficient observed at baseline to that observed post stimulation showed a trend level decrease in correlation between these two time periods (Fischer’s z transform: z = 1.04, p = 0.15).
Although participation in CME activities showed a trend toward improved knowledge, the difference was not statistically significant (p = 0.150) (Table 5 ).
Models comparing responders vs non-responders were adjusted for age, sex, smoking status, baseline DAS28-CRP, and baseline glucocorticoid use; smoking status showed a trend toward association in these models (p < 0.15) but did not reach conventional statistical significance (p ≥ 0.05).
At the time of ROSC, the ECMO showed a trend towards better hemodynamics with higher MAP 131 vs. 89 mmHg ( p = 0.15).
CMT showed a trend of reduction (P=0.15) to 221.6±89.2μ at last follow-up.
Only the variables that appeared significant, or that showed a trend for significance (RR<0.7 or RR>1.3 and p<0.15) were considered in a multivariate model.